Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas. Show more
Location: 21 Waterway Avenue, The Woodlands, TX, 77380, United States | Website: https://autonomix.com | Industry: Medical Devices | Sector: Healthcare
Market Cap
6.299M
52 Wk Range
$0.96 - $21.49
Previous Close
$1.06
Open
$1.05
Volume
124,326
Day Range
$1.02 - $1.07
Enterprise Value
-4.392M
Cash
8.589M
Avg Qtr Burn
-2.253M
Insider Ownership
8.06%
Institutional Own.
4.96%
Qtr Updated
06/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|